Combination Cytoreductive Surgery, Radiotherapy, or Ablation for De Novo Metastatic Prostate Cancer: The IP2-ATLANTA Internal Pilot, Phase 2, Randomised Controlled Trial [0.03%]
初始转移性前列腺癌联合细胞减灭术、放疗或消融的IP2-ATLANTA内部预试验二期随机对照试验
Martin J Connor,Taimur T Shah,Johanna Sukumar et al.
Martin J Connor et al.
The radical arm included treatment of the prostate with external beam radiotherapy along with pelvic lymph node radiotherapy (PLNRT), if involved, or cytoreductive radical prostatectomy with PLND, if involved, both followed by SABR for metastases.
Postoperative Radiation Therapy and Controversies Regarding Hormonal Therapy in the Management of Prostate Cancer [0.03%]
前列腺癌治疗中的术后放疗及有关激素治疗的争议问题
Vérane Achard,Alan Dal Pra,Paul Sargos
Vérane Achard
Biochemical recurrence (BCR) after radical prostatectomy (RP) remains a clinical challenge, with significant heterogeneity in outcomes and optimal management strategies.
Debate 1: High-Risk Localized Prostate Cancer: Why Combination Hormone Therapy and Radiotherapy is the Optimal Treatment Strategy for Most Men [0.03%]
高危局限性前列腺癌：为何联合激素治疗和放疗是大多数患者的首选治疗策略？
Michael K Rooney,Zakaria El Kouzi,Ramez Kouzy et al.
Michael K Rooney et al.
Despite the longstanding use of radical prostatectomy (RP) and definitive radiotherapy (RT) with androgen deprivation therapy (ADT) as primary treatment options, there remains a lack of randomized data directly comparing these modalities.
Debate 1: Radical Prostatectomy For the Right Patient With High-Risk Prostate Cancer [0.03%]
高危前列腺癌适宜患者手术治疗辩论一——根治性前列腺切除术
Vinaik M Sundaresan,Michael S Leapman
Vinaik M Sundaresan
In this article, we distill the following 5 evidence-based arguments that commonly motivate patients to select radical prostatectomy as initial treatment of 'high-risk' prostate cancer. The first is that surgery alone provides excellent long-term cancer control and disease-related survival....Second, radical prostatectomy provides definitive local and regional disease staging, serving as the backbone for multimodality treatment if needed. Third, the sequencing of surgery before radiation is viewed as preferable beca by preserving options for effective local salvage.
Alexithymia and its influence on perceived social support, stress, and help-seeking attitudes in men undergoing radical prostatectomy [0.03%]
alexithymia对社交支持、压力以及前列腺癌根治术后男性求医态度的影响
Xiaoli Zhang,Lijie Huang,Feijie Wang et al.
Xiaoli Zhang et al.
Background: Men undergoing radical prostatectomy for prostate cancer often exhibit reluctance to seek professional psychological help.
Atypical intraductal proliferation (AIP) of the prostate: Findings in repeat biopsy or radical prostatectomy in patients who met pathologic criteria for active surveillance [0.03%]
前列腺非典型导管增生(AIP):符合主动监测病理标准患者的重复活检或根治性前列腺切除术结果
Ruihe Lin,Huili Li,Ezra Baraban et al.
Ruihe Lin et al.
The clinical significance of 'atypical intraductal proliferation' (AIP) is uncertain when found in prostate needle biopsy without intraductal carcinoma (IDC-P) or intermediate/high-grade prostate carcinoma (PCa). A retrospective review iden...
Comment on "Risk factors and risk-stratification model of biochemical failure in patients with positive surgical margin after robot-assisted radical prostatectomy" [0.03%]
关于“阳性切缘的机器人辅助根治性前列腺切除术患者 Biochemical 复发的风险因素及风险分层模型”的讨论
Amogh Verma,Rachana Mehta,Ranjana Sah
Amogh Verma
Clinical Trial Protocol: Impact of Testosterone Replacement Therapy on Functional and Oncological Outcomes Following Radical Prostatectomy (ENFORCE Study) [0.03%]
术后睾酮替代治疗对根治性前列腺切除术功能和肿瘤结局影响的临床试验方案（ENFORCE研究）
Diederik Baas,Joost van Drumpt,Lambertus Kiemeney et al.
Diederik Baas et al.
Background and objective: Testosterone deficiency (TD) affects 18-38% of men undergoing radical prostatectomy (RP) for localised prostate cancer and may impair postoperative sexual rehabilitation.
Letter to Editor: Preoperative membranous urethra length and urinary continence following radical prostatectomy: a systematic review and meta-analysis [0.03%]
写信给编辑：系统回顾和荟萃分析术前膜尿道长度与根治性前列腺切除术后控尿的关系
Xiniming Zhao,Xiunan Li,Guangzhen Wu
Xiniming Zhao
Extended pelvic lymphadenectomy does not improve biochemical recurrence in high-risk prostate cancer patients treated with robot-assisted radical prostatectomy: a propensity-matched comparison of two institutions [0.03%]
延长盆腔淋巴结清扫术不能改善接受机器人辅助前列腺癌根治术的高危前列腺癌患者的生化复发：两个中心的倾向匹配对比研究
Sohei Iwagami,Haruka Miyai,Takahito Wakamiya et al.
Sohei Iwagami et al.
Methods: We identified 275 patients who underwent robot-assisted radical prostatectomy for high- or very high-risk prostate cancer, as defined by the National Comprehensive Cancer Network risk categories, at two centers between May 2013 and March 2021.
耗时 0.12376 秒，为您在
48223910
条记录里面共找到 10000 篇文章 [XML]